China Tian Yuan Healthcare Group Limited (HK:0557)
:0557
Top Page
China Tian Yuan Healthcare Group Limited
(0557)
Select Model
Select Model
Rating:48Neutral
Price Target:
HK$0.69
▼(-1.00% Downside)
Action:ReiteratedDate:01/15/26
The score is primarily held down by weak financial performance driven by declining revenue and ongoing losses. Technicals are mixed-to-modestly supportive with price above key short-term averages but negative MACD. Valuation remains constrained due to loss-making earnings (negative P/E) and no dividend yield data.
Positive Factors
Diversified Business Model
China Tian Yuan’s mix of traditional Chinese medicine, Western pharmaceuticals and healthcare services, plus partnerships with hospitals and clinics, creates diversified revenue streams and distribution channels. This reduces single-product dependence, supporting resilience and cross-selling opportunities over months.
Negative Factors
Sharp Revenue Decline
A roughly 44% year-over-year revenue decline signals material loss of scale or demand and weakens market position. Sustained top-line contraction compresses operating leverage, reduces ability to absorb fixed costs, and undermines capacity to invest in product development or distribution over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Business Model
China Tian Yuan’s mix of traditional Chinese medicine, Western pharmaceuticals and healthcare services, plus partnerships with hospitals and clinics, creates diversified revenue streams and distribution channels. This reduces single-product dependence, supporting resilience and cross-selling opportunities over months.
Read all positive factors
China Tian Yuan Healthcare Group Limited (0557) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$185.53M
Dividend YieldN/A
Average Volume (3M)3.33K
Price to Earnings (P/E)―
Beta (1Y)-0.68
Revenue Growth-43.78%
EPS Growth-118.13%
CountryHK
Employees34
SectorHealthcare
Sector Strength45
IndustryTravel Lodging
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.07
Price to Sales (P/S)7.73
P/FCF Ratio19.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Tian Yuan Healthcare Group Limited Business Overview & Revenue Model
Company Description
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Bu...
How the Company Makes Money
The company generates revenue through multiple streams, primarily by selling its pharmaceutical products and healthcare services. Key revenue streams include the sale of prescription and over-the-counter medications, traditional Chinese medicine p...
China Tian Yuan Healthcare Group Limited Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
45
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.41M | 26.84M | 45.23M | 54.22M | 94.59M | 56.34M |
| Gross Profit | 21.80M | 14.91M | 24.98M | 34.83M | 71.31M | 37.57M |
| EBITDA | -30.06M | -27.22M | -15.79M | -13.08M | -2.89M | -102.17M |
| Net Income | -46.01M | -34.24M | -15.48M | -29.04M | -16.85M | -65.10M |
Balance Sheet | ||||||
| Total Assets | 263.11M | 260.93M | 302.95M | 333.55M | 376.40M | 381.30M |
| Cash, Cash Equivalents and Short-Term Investments | 28.29M | 27.05M | 26.73M | 31.60M | 77.89M | 71.08M |
| Total Debt | 40.80M | 45.97M | 45.91M | 51.13M | 59.66M | 55.06M |
| Total Liabilities | 90.61M | 84.98M | 87.77M | 91.52M | 92.35M | 83.91M |
| Stockholders Equity | 193.98M | 194.68M | 230.26M | 224.30M | 256.25M | 267.53M |
Cash Flow | ||||||
| Free Cash Flow | 7.17M | 10.67M | 4.51M | -31.71M | 14.86M | 49.20M |
| Operating Cash Flow | 7.18M | 10.69M | 5.10M | -30.36M | 16.32M | 49.54M |
| Investing Cash Flow | -4.50K | -3.00K | 364.00K | -1.23M | -1.42M | -11.22M |
| Financing Cash Flow | -10.88M | -10.85M | -8.77M | -12.49M | -7.22M | -2.54M |
China Tian Yuan Healthcare Group Limited Technical Analysis
Negative
0.70
Price Trends
0.62
Negative
0.69
Negative
0.77
Negative
Market Momentum
-0.05
Negative
35.70
Neutral
65.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0557, the sentiment is Negative. The current price of 0.7 is above the 20-day moving average (MA) of 0.51, above the 50-day MA of 0.62, and below the 200-day MA of 0.77, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 35.70 is Neutral, neither overbought nor oversold. The STOCH value of 65.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0557.
China Tian Yuan Healthcare Group Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | HK$342.78M | -1.67 | -2.56% | ― | 3.58% | -91.61% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$203.97M | -0.13 | -15.88% | ― | -2.75% | -17.31% | |
48 Neutral | HK$185.53M | -8.21 | -33.69% | ― | -43.78% | -118.13% | |
47 Neutral | HK$213.39M | -0.13 | -18.68% | ― | -3.51% | -15.27% | |
41 Neutral | HK$937.94M | -0.41 | -20.38% | ― | 798.63% | 56.55% | |
40 Neutral | HK$476.35M | -0.21 | -29.62% | ― | -0.60% | 34.74% |
* Healthcare Sector Average
HK:0557
China Tian Yuan Healthcare Group Limited
0.47
-0.03
-7.00%
HK:0219
Shun Ho Property Investments Ltd
0.67
0.11
19.64%
HK:0355
Century City International Holdings Limited
0.07
<0.01
9.52%
HK:0617
Paliburg Holdings Limited
0.18
-0.22
-54.25%
HK:0078
Regal Hotels International Holdings Limited
0.53
-0.37
-41.11%
HK:0199
ITC Properties Group Limited
0.92
0.72
360.00%
China Tian Yuan Healthcare Group Limited Corporate Events
China Tian Yuan Healthcare Details Valuation and Compliance for 70% Stake Acquisition
Jan 23, 2026
China Tian Yuan Healthcare Group Limited has provided further details on its previously announced acquisition of a 70% equity interest in a target company for RMB2.1 million, confirming that the valuation of the target as at 31 October 2025 was se...
China Tian Yuan Healthcare Seeks Listing Rules Waiver on Acquisition Disclosure
Jan 22, 2026
China Tian Yuan Healthcare Group Limited has applied for a waiver from strict compliance with Rule 14.60A of the Hong Kong Listing Rules to extend the deadline for publishing information related to its proposed acquisition of a 70% equity interest...
China Tian Yuan Healthcare Accelerates 70% Stake Acquisition via Supplemental Agreement
Jan 8, 2026
China Tian Yuan Healthcare Group Limited has signed a supplemental agreement to revise the terms of its planned acquisition of a 70% equity interest in a target company for RMB2.1 million, deciding not to proceed with a previously planned capital ...
China Tian Yuan Healthcare to Acquire 70% Stake in Healthcare Target for RMB2.1 Million
Dec 31, 2025
China Tian Yuan Healthcare Group Limited, through an indirect wholly owned subsidiary, has agreed to acquire a 70% equity interest in an unnamed target company for RMB2.1 million, subject to conditions precedent under an equity transfer agreement ...
China Tian Yuan Healthcare Clarifies Internal Reshuffle of Controlling Shareholder
Dec 29, 2025
China Tian Yuan Healthcare Group Limited announced an internal reorganisation of its controlling shareholder’s shareholding structure, under which Ningxia Tianyuan Manganese Industry Group Co., Ltd. transferred its 100% equity interest in Ti...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.